Remove company medidata-dassault-systemes-company
article thumbnail

Lambda and Medidata team up to automate clinical trial data

Pharmaceutical Technology

Medidata, part of Dassault Systèmes, has partnered with Lambda Therapeutics to automate and consolidate data management processes for improved clinical trial efficiency. Through the tie-up, both companies aim to safely provide advanced data for faster insights.

article thumbnail

Digital biomarkers in pharma: Q&A with Medidata’s Mark Matson 

Drug Discovery World

DDW sits down with Mark Matson, Senior Solution Specialist for Sensor Cloud at Medidata, a Dassault Systèmes company, about the use of digital biomarkers in life sciences and how they can help advance our understanding of disease. . Companies are using sensors that we can put on our wrist or chest and capture all types of data.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Propelling clinical research into the 21st century

pharmaphorum

At Medidata, a Dassault Systèmes company, we saw these efforts first hand and now, two years on, we have taken stock of where our sector is. Half of respondents (51%) said reliance on historical systems and traditional processes could prevent some of these changes from becoming permanent. Pete Buckman is SVP at Medidata.

article thumbnail

Medidata launches cloud platform to gather clinical trial data from sensors

pharmaphorum

Medidata has launched Sensor Cloud, a platform to manage a range of sensor and digital health technology data during clinical trials. In October last year, Medidata bought the digital biomarker firm MC10, adding more clinical analytics and biosensor technology to its cloud offering.